RS RESEARCH

rs-research-logo

RS Research is a clinical-stage biotechnology start-up developing novel nanomedicines. We have discovered a novel drug delivery platform with which we currently have development programs in various preclinical and clinical stages for therapies to treat patients fighting cancer. Our nanocarrier platform (Sagitta®) is highly tunable with a plug & play approach, allowing rapid development of targeted nanomedicines with superior performance aiming multiple indications. Along with moving our own can... didates toward clinic, we provide preclinical services to industrial and academic partners. We have specific expertise in biosimilar characterization as well as in vivo experiment design and implementation. Our GMP certified production facility is the first cytotoxic-capable clinical batch-size contract organization for such services in the region.

#SimilarOrganizations #People #Financial #Website #More

RS RESEARCH

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2015-03-05

Address:
Istanbul, Istanbul, Turkey

Country:
Turkey

Website Url:
http://www.rsresearch.net

Total Employee:
11+

Status:
Active

Contact:
+90 530 760 67 62

Email Addresses:
[email protected]

Total Funding:
14.26 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.


Current Advisors List

sena-nomak_image

Sena Nomak Co-Founder and Chief Operating Officer @ RS Research
Board_member
2015-03-05

rana-sanyal_image

Rana Sanyal Co-Founder and Chief Science Officer @ RS Research
Board_member
2015-03-05

gokhan-guner_image

Gokhan Guner Board Observer @ RS Research
Board_observer
2017-04-01

Founder


rana-sanyal_image

Rana Sanyal

sena-nomak_image

Sena Nomak

Investors List

eczacıbasi-momentum_image

Eczacıbasi Momentum

Eczacıbasi Momentum investment in Series A - RS Research

gen-pharmaceuticals_image

Gen Pharmaceuticals

Gen Pharmaceuticals investment in Series A - RS Research

i-stanbul-portföy-yönetimi_image

İstanbul Portföy Yönetimi

İstanbul Portföy Yönetimi investment in Series A - RS Research

act-venture-partners_image

ACT Venture Partners

ACT Venture Partners investment in Convertible Note - RS Research

act-venture-partners_image

ACT Venture Partners

ACT Venture Partners investment in Seed Round - RS Research

Official Site Inspections

http://www.rsresearch.net Semrush global rank: 7.87 M Semrush visits lastest month: 420

  • Host name: rsresearch.net
  • IP address: 35.246.155.131
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "RS Research"

Home - RS Research

RS Research is a biotechnology start-up discovering and developing smart nanomedicines for targeted chemotherapy. Our innovative drug delivery technology can increase the effect of …See details»

About Us - RS Research

RS Research is a clinical stage biotechnology start-up discovering and developing smart nanomedicines for targeted chemotherapy. Bringing …See details»

Careers - RS Research

RS Research is a clinical-stage biotechnology start-up, developing innovative therapies to win the fight against cancer. Our novel drug delivery technology promises a “cure with a smile” for …See details»

RS Research - Crunchbase Company Profile & Funding

RS Research is a pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform. View contacts …See details»

RS Research - LinkedIn

RS Research is a clinical-stage biotechnology start-up discovering and developing smart nanomedicines, based on innovative drug delivery platform Sagitta® for targeted chemotherapy.See details»

Founder Lodge | Exchange with founders who raised capital, hired ...

RS Research is a clinical stage biotechnology start-up discovering and developing smart nanomedicines. based on innovative drug delivery platform Sagitta® for targeted chemotherapy.See details»

RS Research | LinkedIn

RS Research is a clinical-stage biotechnology start-up discovering and developing smart nanomedicines, based on innovative drug delivery platform Sagitta® for targeted chemotherapy.See details»

RS Research Company Profile 2024: Valuation, Funding

Operator of a clinical-stage biotechnology company intended to discover and develop nanomedicines for targeted chemotherapy.See details»

RS Research - T-DEB Company Profile

RS Research is a company operating in Pharmaceutical, biotechnology, oncology fields. Visit their company profile to get more information about their innovative solutions.See details»

RS Research - Craft

RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy. It also acts as a service provider for pre-clinical …See details»

Contact - RS Research

RS Research is a biotechnology start-up discovering and developing smart nanomedicines for targeted chemotherapy. Our innovative drug delivery technology can increase the effect of …See details»

RS Research - Overview, News & Competitors | ZoomInfo.com

RS Research contact info: Phone number: +90 5307606762 Website: www.rsresearch.net What does RS Research do? RS Research is a clinical-stage biotechnology start-up developing …See details»

RS Research - Products, Competitors, Financials, Employees ...

RS Research operates as a clinical-stage biotechnology company focused on the discovery and development of smart nanomedicines for targeted chemotherapy. Use the CB Insights …See details»

RS Research Company Information - Funding, Investors, and More

Jan 1, 2021 · Get information on funding, investors, industries, and more for RS Research. See RS Research company profile and funding data.See details»

RS Research Announces Dose Escalation in the Phase I Clinical …

Jul 18, 2022 · RS Research, a clinical-stage biotechnology start-up developing smart nanomedicines for targeted chemotherapy, announced the progress of its leading candidate …See details»

ResearchGate | Find and share research

Share your research, collaborate with your peers, and get the support you need to advance your career. Get in-depth stats on who's been reading your work and keep track of your citations. …See details»

Research Organization - an overview | ScienceDirect Topics

Individual researchers generate data to varying degrees. Research organizations (i.e., think tanks, policy institutes, and research centers) also produce statistics through their own data collection …See details»

RS Research Announces Poster Presentation at the ESMO TAT …

Mar 15, 2023 · RS Research, a clinical-stage biotechnology start-up developing smart nanomedicines for targeted chemotherapy, announced the acceptance of a poster …See details»

Research.gov - Homepage - National Science Foundation, NSF

Research.gov is a partnership of Federal, research-oriented grant making agencies with a shared vision of increasing customer service for applicants while streamlining and standardizing …See details»

RS Research Announces First Patient Dosed in Phase I Clinical Trial …

Dec 20, 2021 · RS Research, a clinical-stage biotechnology start-up developing smart nanomedicines for targeted chemotherapy aiming to provide cancer patients with an optimal …See details»

linkstock.net © 2022. All rights reserved